Mary Madison, RN, RAC-CT, CDP
Clinical Consultant – Briggs Healthcare
Since the launch of the National Partnership, significant reductions in the prevalence of antipsychotic medication use in long-stay nursing home residents have been documented. The National Partnership continues to work with state coalitions and nursing homes to reduce that rate even further. Recently, CMS announced a new national goal, involving a 15 percent reduction of antipsychotic medication use by the end of 2019 for long-stay residents in those homes with currently limited reduction rates. This goal builds on the progress made to date and expresses the Partnership’s commitment to continue this important effort.
While the initial focus was on reducing the use of antipsychotic medications, the Partnership’s larger mission is to enhance the use of non-pharmacologic approaches and person-centered dementia care practices.
The latest data has been posted to the National Partnership to Improve Dementia Care in Nursing Homes website:
- Antipsychotic Medication Use Data Report 2020Q4 – Updated 07.30.2021 (3 pages)
- Antipsychotic Use by State 2020Q1-2020Q4 – Updated 07.30.2021(Excel spreadsheet)
- Late Adopter Data Report 2020Q4 – Updated 07.30.2021(3 pages)
- Late Adopter Antipsychotic Use by State 2020Q4 – Updated 07.30.2021(Excel spreadsheet)
Below is one of the graphs from the 2020Q4 Antipsychotic Medication Use report. Note that it shows the ranking of states. Hawaii holds the pole position for the best in show while Wyoming ranks at the bottom.